Skip to main content

Medical Education Nursing Contact Us

Home
Find a Doctor
Find a Location
Services
Patients and Visitors
MyChart Login

Search

Services

Spartanburg Regional Healthcare System is dedicated to providing patient-centered care to communities we serve. Explore the wide range of services we offer.

Frequently Visited Services

Behavioral Health
Breast Health
Cancer
Emergency
Heart

Hospice
Imaging
Immediate Care
Maternity
Pharmacy

Rehabilitation
Spine
Sports Medicine Institute
Telehealth
Weight Loss

Patients and Visitors

Whether you’re seeking care or visiting a loved one, Spartanburg Regional Healthcare System is here for you. Our compassionate team provides the resources and support you need so you can focus on what is important.

Patients

Advance Directives
Chaplain Services
ER Wait Times
Language Services
Medical Records
MyChart Help and Information
Patient Rights
Planning Discharge
Pre-admission Testing (PAT)
Recognize Your Caregiver
When to Go Where

Visitors

Directions & Maps
Gift Shops
Hotel Information
Visitor Guidelines
Volunteer
Wireless Internet

Financial

Bill Pay
Financial Assistance Program
Insurance Information
Pricing Policies
No Surprises Act

Find a Doctor
Find a Location
Services
Patients and Visitors
MyChart Login
Medical Education
Nursing
Contact Us

Search

Menu

Search

Clinical Research Trials

Search by Name

(-) Hematologic Cancer
Clear all filters

Status

Closed
Complete
Accepting Participants

Disease Site

Oncology
Symptom Management & Cancer Control
Thoracic Cancer
Breast Cancer
(-) Hematologic Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Precision Medicine & Rare Tumors
Cancer Care Delivery Research (CCDR)
Cardiology
Phase 1
Head & Neck Cancer
Cutaneous & Sarcoma Cancer
Gynecologic Cancer
Other
Neurologic Cancer
Nephrology
Neo-Natal
Trauma
Wound Healing - Infectious Disease

Study Type

Oncology

Cancer Care Delivery Research (CCDR)

Leukemia, Acute Lymphocytic (ALL), Adolescent & Young Adult (ACCL16N1CD)
Closed

Hematologic Cancer

Myelodysplastic Syndromes & Acute Myeloid Leukemia, (Connect® MDS/AML) Observational
Accepting Participants
A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant (MMY3021)
Closed
A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (Celegene CC-92480-MM-001)
Closed
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned
Closed
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies (2018-02)
Closed
Leukemia, Acute Promyelocytic (EA9131) Observational
Closed
Leukemia, Chronic Lymphocytic (CLL), Untreated Older Patients (A041702)
Closed
Leukemia, Chronic Lymphocytic (CLL), Untreated Younger Patients (EA9161)
Closed
Leukemia, Chronic Lymphocytic (PCYC-1134M), Registry
Closed
Multiple Myeloma, Untreated, Stem Cell Transplant Not Planned (54767414MMY3019)
Closed
Multiple Myeloma: 1st Line Therapy (E1A11)
Closed
Myelodysplastic Syndromes (MDS) (NHLBI-MDS) Observational
Closed
Myelofibrosis or Essential Thrombocythemia (INCB-MA-MF-401) Registry
Closed
Lymphoma, Diffuse Large B-Cell, Relapsed or Refractory (1562-201)
Complete
Plasmacytoma of the Bone (A061402)
Complete
Randomized, Open-label, 2-Arm, Multicenter, Phase 3 Study of Venetoclax and Azacitidine Versus Best Supportive Care as Maintenance Therapy for Patients With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy (VIALE-M)
Closed
Study of Lenalidomide/ Ixazomib/ Dexamethasone/ Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM (AFT-41)
Closed

Oncology

A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects With Chronic Lymphocytic Leukemia (AZ ASSURE)
Closed
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (S1826)
Closed
Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma (S1608)
Closed

Precision Medicine & Rare Tumors

Lymphoma, Hodgkin (CA209655) Observational
Closed
Leukemia, Chronic Myeloid (S1712)
Complete
Lymphoma, Diffuse Large B-Cell, Treatment Naïve (DB102-02)
Complete
Lymphoma, Mantle Cell, Previously Treated (AFT-32)
Complete

Phase 1

Multiple Myeloma, Refractory to Lenalidomide (A061202)
Closed

ABOUT US

Board of Trustees
Community Health
Diversity and Inclusion
Media Policy
Mission and Vision

News - Discover Health
Policies
Quality
Social Media Guidelines
Spartanburg Regional Healthcare System History
Spartanburg Regional Healthcare System Museum
The Spartanburg Community

RESOURCES

Careers
Employees
Price Transparency
Information for Vendors
Integrity Hotline

Medical Staff Services
Project SEARCH
Safety and Awareness
Sponsorship
Health Library
Transfer Center
Transportation Services
Volunteer

IMPORTANT LINKS

Apella Health Management
Discover Health
Regional HealthPlus
Southeastern Health Partners
Spartanburg Regional Foundation

© 2024 Spartanburg Regional Healthcare System. All Rights Reserved.